Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and Immune Effects of Peri-Transplantation JAK Inhibition for Myelofibrosis.
Rathje K, Gagelmann N, Badbaran A, Langebrake C, Dadkhah A, Richter J, Massoud R, Schäfersküpper M, Marquard FE, Oechsler S, Klyuchnikov E, Rudolph I, Heidenreich S, Niederwieser C, Lueck C, Janson D, Wolschke C, Fehse B, Ayuk F, Kröger N. Rathje K, et al. Among authors: heidenreich s. Am J Hematol. 2024 Nov 16. doi: 10.1002/ajh.27529. Online ahead of print. Am J Hematol. 2024. PMID: 39548811
Sequential Conditioning With FLAMSA Does Not Improve Outcomes of Allogeneic Stem Cell Transplantation in Chronic Myelomonocytic Leukemia Patients.
Massoud R, Klyuchnikov E, Steiner N, Zeck G, Heidenreich S, Langebrake C, Niederwieser C, Rathje K, Gagelmann N, Janson D, Wolschke C, Ayuk F, Kröger N. Massoud R, et al. Among authors: heidenreich s. Transplant Cell Ther. 2024 Oct 16:S2666-6367(24)00696-1. doi: 10.1016/j.jtct.2024.10.003. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39419178 Free article.
Comparable Results Between 8 and 12 Gray TBI in Combination With Fludarabine and Post-Transplant Cyclophosphamide in MRD-Negative but Not in MRD-Positive Acute Lymphoblastic Leukemia Patients Transplanted in First Complete Remission.
Steiner N, Massoud R, Richter J, Perekhrestenko T, Gagelmann N, Niederwieser C, Rathje K, Lastovytska I, Schäfersküpper M, Heidenreich S, Rudolph I, Zeck G, Janson D, Wolschke C, Ayuk FA, Klyuchnikov E, Kröger N. Steiner N, et al. Among authors: heidenreich s. Eur J Haematol. 2024 Sep 19. doi: 10.1111/ejh.14305. Online ahead of print. Eur J Haematol. 2024. PMID: 39300830
Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease: Results from the EQUAL Study.
Magagnoli L, Cozzolino M, Evans M, Caskey FJ, Dekker FW, Torino C, Szymczak M, Drechsler C, Pippias M, Vilasi A, Janse RJ, Krajewska M, Stel VS, Jager KJ, Chesnaye NC; EQUAL study investigators. Magagnoli L, et al. Clin J Am Soc Nephrol. 2024 Oct 1;19(10):1240-1252. doi: 10.2215/CJN.0000000000000510. Epub 2024 Jul 22. Clin J Am Soc Nephrol. 2024. PMID: 39037951
Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation.
Steiner N, Massoud R, Klyuchnikov E, Gagelmann N, Richter J, Niederwieser C, Rathje K, Urbanowicz T, Kunte A, Engelmann J, Ihne C, Lastovytska I, Lindhauer C, Marquard F, Reichard M, Ryzhkova A, Sabauri R, Schäfersküpper M, Seyedi N, Kalogeropoulos G, Heidenreich S, Rudolph I, Zeck G, Janson D, Wolschke C, Ayuk F, Kröger N. Steiner N, et al. Among authors: heidenreich s. Bone Marrow Transplant. 2024 Sep;59(9):1265-1274. doi: 10.1038/s41409-024-02328-w. Epub 2024 Jun 14. Bone Marrow Transplant. 2024. PMID: 38877098 Free PMC article.
187 results